Form 4: Maze Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Atul Dandekar, CSBO of Maze Therapeutics, Inc., sold 7,500 shares of common stock on September 29, 2026 for $27.06 per share.
Summary
- Option exercise/conversion: acquired 7,500 Common Stock at $10.42 ($78,150) on September 29, 2026; holds 39,816 after (Direct).
- Open-market sale: disposed of 7,500 Common Stock at $27.06 ($202,921) on September 29, 2026; holds 32,316 after (Direct).
- Option exercise/conversion: disposed of 7,500 Stock Option (Right to Buy) on September 29, 2026; holds 6,643 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $202,921 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Atul Dandekar — Officer (CSBO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-29 | Option exercise/conversion | Common Stock | 7,500 | $10 | $78.2K | 39,816 |
| 2026-09-29 | Open-market sale | Common Stock | 7,500 | $27 | $202.9K | 32,316 |
| 2026-09-29 | Option exercise/conversion | Stock Option (Right to Buy) | 7,500 | — | — | 6,643 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-29 | Option exercise/conversion (7,500 shares) |
| 2026-09-29 | Open-market sale (7,500 shares) |
| 2026-09-29 | Option exercise/conversion (7,500 shares) |
Keywords
insider transaction, Form 4, MAZE, Maze Therapeutics, Inc., bearish, Atul Dandekar
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.